FINWIRES · TerminalLIVE
FINWIRES

CIBC Confirms Outperformer Rating and Target of US$28 on Docebo After Inspire 2026 Conference

-- CIBC Capital Markets maintained its outperformer rating and price target of US$28.00 on the shares of Docebo (DCBO.TO, DCBO) following the company's annual Inspire user conference in Miami.

The bank noted the company preannounced "stronger-than-expected" preliminary first-quarter expectations, raised 2026 guidance, and announced several enhancements to the core platform and a number of AI-enabled product releases at the conference. The increase in outlook, the bank believes, is directly attributed to strength in the underlying enterprise business and includes two more-than $1 million enterprise expansion deals signed in Q1.

"Overall we came away from the conference increasingly confident in F2026 (increased) guidance, supported by solid underlying ARR growth and a refreshed go-to-market and product strategy that refocuses on enterprise and consistent platform improvement," said analyst Erin Kyle. "We continue to view shares as attractively valued, trading at 7.3x 2027E EV/EBITDA and 1.6x 2027E EV/Sales which is a discount to small-cap SaaS peers at ~8x and ~2x, respectively."

CIBC expects double-digit growth in annual recurring revenue (ARR) to continue to be supported by growth in the underlying business, with a gradually declining impact from Dayforce churn offset by high double-digit ARR growth from the 365Talents business, as the year progresses. It revised its estimates to reflect stronger-than-expected Q1 results and raised full-year guidance for consolidated revenue, subscription revenue and adjusted EBITDA.

For fiscal 2026, CIBC forecast subscription revenue growth of 11% and adjusted EBITDA margins of 20.3% for the full year. It also increased its adjusted EBITDA estimate for fiscal 2027 and now model margins of 22.2%.

"We expect margin expansion should be supported by continued operating leverage in G&A and S&M as the company leverages AI internally," added Kyle.

Price: $24.24, Change: $-2.00, Percent Change: -7.62%

相關文章

Asia

SPIC 工業金融公司第一季獲利成長 0.3%,股價下跌 4%。

上交所上市公司國家石油投資集團有限公司(SPIC Industry-Finance,股票代號:000958)公佈第一季歸屬於母公司股東的淨利為11.2億元人民幣,較上年同期的11.1億元成長0.3%。 根據週五提交給上海證券交易所的文件,每股收益從0.0859元人民幣降至0.0643元。 營業收入較去年同期下滑17%,從33億元降至27.3億元。 這家供熱供電服務提供商的股價在最近的交易中下跌了4%。

$SHE:000958
Asia

Uni-Bio Science 計劃替換即將到期的股票期權計劃

根據週四提交給香港交易所的文件,優利生物科技(港交所代碼:0690)擬終止現有的股票選擇權計劃,並採用新的計劃。 該公司股價在周五上午交易時段下跌近1%。 現行計畫於2016年9月實施,將於今年9月到期,屆時將不再授予新的選擇權。 截至公告發布之日,該計劃下仍有4.206億份選擇權未行使。 該公司表示,新計劃旨在繼續激勵和獎勵符合資格的參與者的貢獻。

$HKG:0690
Asia

太平洋石灰水泥公司與巴布亞紐幾內亞電力生產商簽署諒解備忘錄

根據週五提交給澳洲證券交易所的文件顯示,太平洋石灰水泥公司(ASX:PLA)與巴布亞紐幾內亞電力營運商Dirio Gas & Power簽署了一份諒解備忘錄(MOU),旨在為中央石灰水泥項目開發專用電力基礎設施。 文件稱,該諒解備忘錄為雙方合作建造一條從中央省發電站到太平洋石灰水泥計畫區域的66千伏專用輸電線路奠定了基礎。 文件也指出,根據輸電線路的容量和審批情況,電力供應可能會擴展到沿線附近的社區。 週五下午交易中,太平洋石灰水泥公司的股價下跌了近2%。

$ASX:PLA